Boehringer Ingelheim | Law Firm Newswire

Southfield, MI (Law Firm Newswire) October 2, 2013 – Pradaxa is suspected of causing strokes, brain hemorrhages, heart attacks, gastrointestinal bleeding and death. “Brenda Medley filed a wrongful death lawsuit against Boehringer Ingelheim alleging their anti-coagulant, Pradaxa, contributed to, or caused, her husband’s death. She is asking the court for compensatory and punitive damages, pain and suffering and medical costs,” explained Daren Monroe, of Litigation Funding Corporation, Michigan. Howard Medley was given Pradaxa in 2011 for atrial fibrillation. In 2012, he was rushed to hospital for excessive blood loss, supposedly linked to the drug. He received a blood transfusion. He […]


Continue reading full article »

Waxahachie, TX (Law Firm Newswire) July 29, 2013 – A Texas resident has filed a lawsuit alleging that Pradaxa, a blood thinner, resulted in severe internal bleeding. The manufacturer of Pradaxa, Boehringer Ingelheim, is facing a number of similar lawsuits alleging that their blood-thinning medication causes internal hemorrhaging and that consumers are not being adequately warned. “Anyone experiencing any issues after taking Pradaxa should immediately speak to their doctor,” warned Waxahachie personal injury lawyer John Hale. The lawsuit was filed this May in the U.S. District Court for the Eastern District of Texas by a plaintiff who first began taking […]


Continue reading full article »

Chicago, IL (Law Firm Newswire) May 8, 2013 – A wrongful death lawsuit has been filed claiming that the drug Pradaxa caused a fatal brain hemorrhage. The plaintiff, Martha Lesnick, claims that her husband started taking Pradaxa in January of 2011 as part of a blood-thinning treatment and suffered massive bleeding in his brain two months later, which led to his death. The lawsuit joins ongoing multi-district litigation (MDL) in Illinois federal court. “In this case, the plaintiff alleges that the drug manufacturer failed to adequately warn her husband and his doctor of the risk of bleeding,” said Paul Greenberg, […]


Continue reading full article »